Breaking News Instant updates and real-time market news.

FSTX

F-star Therapeutics

$6.99 /

+0.06 (+0.87%)

07:37
06/09/21
06/09
07:37
06/09/21
07:37

B. Riley starts F-star Therapeutics at Buy, sees 307% potential upside

B. Riley analyst Justin Walsh last night initiated coverage of F-star Therapeutics with a Buy rating and $28 price target, which represents 307% potential upside from current levels. F-star is a clinical-stage immuno-oncology biotech company whose bispecific antibody platform has moved three assets into the clinic targeting unmet needs in the multi-billion-dollar solid tumor checkpoint inhibitor market, Walsh tells investors in a research note. The analyst sees the "steady cadence of data readouts" expected across F-star's clinical assets as providing the "potential fuel needed to further de-risk its platform and pipeline."

  • 09

    May

FSTX F-star Therapeutics
$6.99 /

+0.06 (+0.87%)

06/08/21 B. Riley
F-star Therapeutics initiated with a Buy at B. Riley
04/15/21 Oppenheimer
Opco starts F-star Therapeutics with Outperform, $30 price target
04/15/21 Oppenheimer
F-star Therapeutics initiated with an Outperform at Oppenheimer
04/08/21 William Blair
F-star Therapeutics initiated with an Outperform at William Blair

TODAY'S FREE FLY STORIES

Hot Stocks
Desktop Metal set to join Russell 2000 Index » 08:09
06/24/21
06/24
08:09
06/24/21
08:09
DM

Desktop Metal

$13.00 /

+0.05 (+0.39%)

Desktop Metal expects to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DM Desktop Metal
$13.00 /

+0.05 (+0.39%)

DM Desktop Metal
$13.00 /

+0.05 (+0.39%)

06/07/21 Lake Street
Lake Street reiterates Sell rating on Desktop Metal as lockup expires
04/26/21 Lake Street
Desktop Metal to face more competition from GE, says Lake Street
03/26/21 Lake Street
Desktop Metal initiated with a Sell at Lake Street
01/29/21 Alliance Global Partners
ExOne upgraded to Buy from Neutral at Alliance Global Partners
DM Desktop Metal
$13.00 /

+0.05 (+0.39%)

DM Desktop Metal
$13.00 /

+0.05 (+0.39%)

DM Desktop Metal
$13.00 /

+0.05 (+0.39%)

Hot Stocks
Corbus says DETERMINE Phase 3 study did not meet primary endpoint » 08:08
06/24/21
06/24
08:08
06/24/21
08:08
CRBP

Corbus Pharmaceuticals

$1.98 /

+0.055 (+2.86%)

Corbus Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRBP Corbus Pharmaceuticals
$1.98 /

+0.055 (+2.86%)

CRBP Corbus Pharmaceuticals
$1.98 /

+0.055 (+2.86%)

10/08/20 H.C. Wainwright
Corbus Pharmaceuticals price target lowered to $3 from $6 at H.C. Wainwright
10/06/20 Roth Capital
Corbus Pharmaceuticals price target lowered to $1.22 from $3 at Roth Capital
09/08/20 Jefferies
Corbus Pharmaceuticals downgraded to Hold from Buy at Jefferies
09/08/20 Oppenheimer
Corbus Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
CRBP Corbus Pharmaceuticals
$1.98 /

+0.055 (+2.86%)

Recommendations
Equinix price target raised to $880 from $820 at Oppenheimer » 08:08
06/24/21
06/24
08:08
06/24/21
08:08
EQIX

Equinix

$803.80 /

-18.61 (-2.26%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EQIX Equinix
$803.80 /

-18.61 (-2.26%)

EQIX Equinix
$803.80 /

-18.61 (-2.26%)

07:50 Today TD Securities
Equinix price target raised to $850 from $800 at TD Securities
07:40 Today JPMorgan
Equinix price target raised to $895 from $861 at JPMorgan
07:04 Today Wells Fargo
Equinix price target raised to $875 from $825 at Wells Fargo
06:35 Today Credit Suisse
Equinix price target lowered to $907 from $932 at Credit Suisse
EQIX Equinix
$803.80 /

-18.61 (-2.26%)

EQIX Equinix
$803.80 /

-18.61 (-2.26%)

EQIX Equinix
$803.80 /

-18.61 (-2.26%)

Hot Stocks
Brickell Biotech announce initiation of Phase 1 study of sofpironium bromide gel » 08:07
06/24/21
06/24
08:07
06/24/21
08:07
BBI

Brickell Biotech

/

+

Brickell Biotech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBI Brickell Biotech
/

+

BBI Brickell Biotech
/

+

04/26/21 Lake Street
Brickell Biotech Phase 3 safety results build confidence, says Lake Street
09/25/20 Lake Street
Approval in Japan validating for Brickell Biotech, says Lake Street
08/28/20 Lake Street
Brickell Biotech initiated with a Buy at Lake Street
08/25/20 Oppenheimer
Brickell Biotech initiated with an Outperform at Oppenheimer
  • 23
    Oct
Recommendations
Acceleron price target raised to $160 from $141 at Oppenheimer » 08:07
06/24/21
06/24
08:07
06/24/21
08:07
XLRN

Acceleron

$122.23 /

-2.28 (-1.83%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XLRN Acceleron
$122.23 /

-2.28 (-1.83%)

XLRN Acceleron
$122.23 /

-2.28 (-1.83%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
XLRN Acceleron
$122.23 /

-2.28 (-1.83%)

  • 01
    Jul
Hot Stocks
Pieris Pharmaceuticals receives orphan drug designation for cinrebafusp alfa » 08:07
06/24/21
06/24
08:07
06/24/21
08:07
PIRS

Pieris Pharmaceuticals

$3.54 /

+0.13 (+3.81%)

Pieris Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PIRS Pieris Pharmaceuticals
$3.54 /

+0.13 (+3.81%)

PIRS Pieris Pharmaceuticals
$3.54 /

+0.13 (+3.81%)

PIRS Pieris Pharmaceuticals
$3.54 /

+0.13 (+3.81%)

PIRS Pieris Pharmaceuticals
$3.54 /

+0.13 (+3.81%)

Hot Stocks
XL Fleet and Rubicon team to accelerate fleet electrification » 08:06
06/24/21
06/24
08:06
06/24/21
08:06
XL

XL Fleet

$8.40 /

+0.42 (+5.26%)

XL Fleet with Rubicon, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XL XL Fleet
$8.40 /

+0.42 (+5.26%)

XL XL Fleet
$8.40 /

+0.42 (+5.26%)

05/18/21 BTIG
XL Fleet price target lowered to $12 from $23 at BTIG
05/18/21 Canaccord
XL Fleet price target lowered to $7.50 from $10 at Canaccord
04/01/21 Canaccord
XL Fleet price target lowered to $10 from $30 at Canaccord
04/01/21 BTIG
XL Fleet price target lowered to $23 from $30 at BTIG
XL XL Fleet
$8.40 /

+0.42 (+5.26%)

XL XL Fleet
$8.40 /

+0.42 (+5.26%)

XL XL Fleet
$8.40 /

+0.42 (+5.26%)

XL XL Fleet
$8.40 /

+0.42 (+5.26%)

Hot Stocks
PTC Therapeutics' Emflaza in DMD shows physical function improvement » 08:06
06/24/21
06/24
08:06
06/24/21
08:06
PTCT

PTC Therapeutics

$43.43 /

+0.05 (+0.12%)

PTC Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PTCT PTC Therapeutics
$43.43 /

+0.05 (+0.12%)

PTCT PTC Therapeutics
$43.43 /

+0.05 (+0.12%)

05/17/21 Truist
PTC Therapeutics price target lowered to $65 from $75 at Truist
04/26/21 Credit Suisse
PTC Therapeutics assumed with a Neutral at Credit Suisse
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
PTCT PTC Therapeutics
$43.43 /

+0.05 (+0.12%)

PTCT PTC Therapeutics
$43.43 /

+0.05 (+0.12%)

Hot Stocks
electroCore announces publication of study on nVNS on Cognitive Performance » 08:06
06/24/21
06/24
08:06
06/24/21
08:06
ECOR

electroCore

$1.69 /

+0.07 (+4.32%)

electroCore announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ECOR electroCore
$1.69 /

+0.07 (+4.32%)

ECOR electroCore
$1.69 /

+0.07 (+4.32%)

10/22/20 Brookline
electroCore initiated with a Buy at Brookline
09/30/20
Fly Intel: Top five analyst initiationsNewPage
09/30/20 Maxim
electroCore initiated with a Buy at Maxim
09/30/20 Maxim
electroCore initiated with a Buy at Maxim
ECOR electroCore
$1.69 /

+0.07 (+4.32%)

Hot Stocks
Longeveron announces abstract on data of Phase 1 trial of Lomecel-B infusion » 08:06
06/24/21
06/24
08:06
06/24/21
08:06
LGVN

Longeveron

$7.51 /

+0.14 (+1.90%)

Longeveron announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LGVN Longeveron
$7.51 /

+0.14 (+1.90%)

LGVN Longeveron
$7.51 /

+0.14 (+1.90%)

  • 12
    Feb
LGVN Longeveron
$7.51 /

+0.14 (+1.90%)

Recommendations
PureCycle Technologies price target raised to $28 from $24 at Oppenheimer » 08:06
06/24/21
06/24
08:06
06/24/21
08:06
PCT

PureCycle Technologies

$25.10 /

+1.75 (+7.49%)

Oppenheimer analyst Noah…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PCT PureCycle Technologies
$25.10 /

+1.75 (+7.49%)

PCT PureCycle Technologies
$25.10 /

+1.75 (+7.49%)

06/07/21 Alembic Global
PureCycle Technologies initiated with an Overweight at Alembic Global
05/24/21 Oppenheimer
Opco starts 'high-ceiling execution story' PureCycle with Outperform
05/24/21 Oppenheimer
PureCycle Technologies initiated with an Outperform at Oppenheimer
04/21/21 Roth Capital
PureCycle Technologies initiated with a Buy at Roth Capital
PCT PureCycle Technologies
$25.10 /

+1.75 (+7.49%)

PCT PureCycle Technologies
$25.10 /

+1.75 (+7.49%)

Hot Stocks
Aravive jumps over 20% in pre-market after its Phase 1b data for AVB-500  08:05
06/24/21
06/24
08:05
06/24/21
08:05
ARAV

Aravive

$5.30 /

+0.03 (+0.57%)

 
ShowHide Related Items >><<
ARAV Aravive
$5.30 /

+0.03 (+0.57%)

ARAV Aravive
$5.30 /

+0.03 (+0.57%)

04/27/21 Piper Sandler
Aravive doses first patient in Phase III AVB-500 trial, says Piper Sandler
03/08/21
Fly Intel: Top five analyst initiations
03/08/21 BTIG
Aravive initiated with a Buy at BTIG
02/17/21 Piper Sandler
Aravive chairman bought $21M of shares, says Piper Sandler
ARAV Aravive
$5.30 /

+0.03 (+0.57%)

Hot Stocks
Kratos Defense awarded $8.6M task order to complete 50shp class turbine engine » 08:04
06/24/21
06/24
08:04
06/24/21
08:04
KTOS

Kratos Defense

$26.87 /

+0.36 (+1.36%)

Kratos Defense &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KTOS Kratos Defense
$26.87 /

+0.36 (+1.36%)

KTOS Kratos Defense
$26.87 /

+0.36 (+1.36%)

06/18/21 Canaccord
Kratos Defense opportunities supports positive outlook, says Canaccord
05/06/21 Noble Capital
Kratos Defense upgraded to Outperform from Market Perform at Noble Capital
03/01/21 Alembic Global
Kratos Defense downgraded to Neutral from Overweight at Alembic Global
02/26/21 Noble Capital
Kratos Defense downgraded to Market Perform from Outperform at Noble Capital
KTOS Kratos Defense
$26.87 /

+0.36 (+1.36%)

KTOS Kratos Defense
$26.87 /

+0.36 (+1.36%)

KTOS Kratos Defense
$26.87 /

+0.36 (+1.36%)

Hot Stocks
Digital Asset, Nasdaq partner to bring Daml to Marketplace Services Platform » 08:04
06/24/21
06/24
08:04
06/24/21
08:04
NDAQ

Nasdaq

$178.08 /

-0.605 (-0.34%)

Digital Asset announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NDAQ Nasdaq
$178.08 /

-0.605 (-0.34%)

NDAQ Nasdaq
$178.08 /

-0.605 (-0.34%)

06/11/21
Fly Intel: Top five analyst initiations
06/11/21 Morgan Stanley
Nasdaq initiated with an Overweight at Morgan Stanley
04/22/21 Wells Fargo
Nasdaq price target raised to $186 from $173 at Wells Fargo
04/22/21 Oppenheimer
Nasdaq price target raised to $182 from $170 at Oppenheimer
NDAQ Nasdaq
$178.08 /

-0.605 (-0.34%)

NDAQ Nasdaq
$178.08 /

-0.605 (-0.34%)

NDAQ Nasdaq
$178.08 /

-0.605 (-0.34%)

Hot Stocks
CSX and Wabtec partner to drive sustainable transportation solutions » 08:04
06/24/21
06/24
08:04
06/24/21
08:04
CSX

CSX

$94.66 /

-0.61 (-0.64%)

, WAB

Wabtec

$81.14 /

+0.2 (+0.25%)

CSX (CSX) and Wabtec…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSX CSX
$94.66 /

-0.61 (-0.64%)

WAB Wabtec
$81.14 /

+0.2 (+0.25%)

CSX CSX
$94.66 /

-0.61 (-0.64%)

06/21/21 Stifel
CSX resumed with a Hold at Stifel
06/15/21 Deutsche Bank
CSX price target raised to $115 from $113 at Deutsche Bank
05/14/21 Stephens
Canadian rail that loses KCS likely to pursue an Eastern rail, says Stephens
04/21/21 Deutsche Bank
CSX price target raised to $113 from $105 at Deutsche Bank
WAB Wabtec
$81.14 /

+0.2 (+0.25%)

03/23/21 Cowen
Wabtec remains positioned to benefit from rail market, says Cowen
02/19/21 Wolfe Research
Wabtec upgraded to Peer Perform from Underperform at Wolfe Research
01/29/21 Citi
Wabtec price target raised to $80 from $65 at Citi
11/13/20 KeyBanc
Wabtec price target raised to $85 from $75 at KeyBanc
CSX CSX
$94.66 /

-0.61 (-0.64%)

WAB Wabtec
$81.14 /

+0.2 (+0.25%)

CSX CSX
$94.66 /

-0.61 (-0.64%)

WAB Wabtec
$81.14 /

+0.2 (+0.25%)

CSX CSX
$94.66 /

-0.61 (-0.64%)

Hot Stocks
Alpine Immune Sciences doses first patient in Synergy trial » 08:03
06/24/21
06/24
08:03
06/24/21
08:03
ALPN

Alpine Immune Sciences

$9.35 /

+0.24 (+2.63%)

, ABBV

AbbVie

$113.99 /

-0.7 (-0.61%)

Alpine Immune Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALPN Alpine Immune Sciences
$9.35 /

+0.24 (+2.63%)

ABBV AbbVie
$113.99 /

-0.7 (-0.61%)

ALPN Alpine Immune Sciences
$9.35 /

+0.24 (+2.63%)

12/21/20 H.C. Wainwright
Alpine Immune Sciences initiated with a Buy at H.C. Wainwright
08/26/20 Cowen
Alpine Immune Sciences initiated with an Outperform at Cowen
08/11/20 Piper Sandler
Alpine Immune Sciences price target lowered to $18 from $21 at Piper Sandler
ABBV AbbVie
$113.99 /

-0.7 (-0.61%)

05/19/21 Piper Sandler
Piper 'incrementally bullish' on Biohaven, AbbVie migraine drugs
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
ALPN Alpine Immune Sciences
$9.35 /

+0.24 (+2.63%)

ABBV AbbVie
$113.99 /

-0.7 (-0.61%)

ABBV AbbVie
$113.99 /

-0.7 (-0.61%)

ABBV AbbVie
$113.99 /

-0.7 (-0.61%)

ALPN Alpine Immune Sciences
$9.35 /

+0.24 (+2.63%)

ABBV AbbVie
$113.99 /

-0.7 (-0.61%)

Hot Stocks
Iridium awarded $30M R&D U.S. Army contract » 08:03
06/24/21
06/24
08:03
06/24/21
08:03
IRDM

Iridium

$40.75 /

+0.12 (+0.30%)

Iridium has been awarded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IRDM Iridium
$40.75 /

+0.12 (+0.30%)

IRDM Iridium
$40.75 /

+0.12 (+0.30%)

04/05/21 William Blair
William Blair upgrades Gogo, sees shares going back to $13-$16
03/03/21
Fly Intel: Top five analyst upgrades
03/03/21 Raymond James
Iridium upgraded to Outperform from Market Perform at Raymond James
03/03/21 Raymond James
Iridium upgraded to Outperform from Market Perform at Raymond James
IRDM Iridium
$40.75 /

+0.12 (+0.30%)

Hot Stocks
CTO Realty Growth to see remaining Daytona Beach land for $67M » 08:02
06/24/21
06/24
08:02
06/24/21
08:02
CTO

CTO Realty Growth

$54.73 /

+1.49 (+2.80%)

CTO Realty Growth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTO CTO Realty Growth
$54.73 /

+1.49 (+2.80%)

CTO CTO Realty Growth
$54.73 /

+1.49 (+2.80%)

05/28/21 BTIG
CTO Realty Growth initiated with a Buy at BTIG
05/03/21 Compass Point
CTO Realty Growth downgraded to Neutral from Buy at Compass Point
02/23/21 B. Riley Securities
CTO Realty Growth price target lowered to $65 from $67 at B. Riley Securities
11/02/20 B. Riley Securities
CTO Realty Growth price target lowered to $67 from $74 at B. Riley Securities
CTO CTO Realty Growth
$54.73 /

+1.49 (+2.80%)

Hot Stocks
Aquestive Therapeutics resubmits new drug application for Libervant » 08:02
06/24/21
06/24
08:02
06/24/21
08:02
AQST

Aquestive Therapeutics

$4.45 /

+0.32 (+7.75%)

Aquestive Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AQST Aquestive Therapeutics
$4.45 /

+0.32 (+7.75%)

AQST Aquestive Therapeutics
$4.45 /

+0.32 (+7.75%)

04/06/21 RBC Capital
Aquestive Therapeutics transferred with an Outperform at RBC Capital
09/28/20 Lake Street
Aquestive Therapeutics price target lowered to $7 from $10 at Lake Street
09/28/20 RBC Capital
Aquestive Therapeutics price target lowered to $7 from $8 at RBC Capital
09/28/20 BMO Capital
Aquestive Therapeutics price target lowered to $13 from $18 at BMO Capital
AQST Aquestive Therapeutics
$4.45 /

+0.32 (+7.75%)

AQST Aquestive Therapeutics
$4.45 /

+0.32 (+7.75%)

Upgrade
Intersect ENT upgraded to Outperform from Market Perform at SVB Leerink » 08:02
06/24/21
06/24
08:02
06/24/21
08:02
XENT

Intersect ENT

$15.97 /

-0.3 (-1.84%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XENT Intersect ENT
$15.97 /

-0.3 (-1.84%)

XENT Intersect ENT
$15.97 /

-0.3 (-1.84%)

05/18/21 Piper Sandler
Piper says Intersect ENT positioned to hit international goal with CE Marks back
03/09/21 Piper Sandler
Piper says Intersect ENT FY21 guidance 'potentially on the conservative side'
01/15/21 Piper Sandler
Intersect ENT price target raised to $23 from $17 at Piper Sandler
01/11/21 Canaccord
Intersect ENT upgraded to Buy from Hold at Canaccord
XENT Intersect ENT
$15.97 /

-0.3 (-1.84%)

Hot Stocks
AbbVie exercises right to acquire TeneoOne and lead asset TNB-383B » 08:02
06/24/21
06/24
08:02
06/24/21
08:02
ABBV

AbbVie

$113.99 /

-0.7 (-0.61%)

AbbVie and Teneobio…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$113.99 /

-0.7 (-0.61%)

ABBV AbbVie
$113.99 /

-0.7 (-0.61%)

05/19/21 Piper Sandler
Piper 'incrementally bullish' on Biohaven, AbbVie migraine drugs
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
ABBV AbbVie
$113.99 /

-0.7 (-0.61%)

ABBV AbbVie
$113.99 /

-0.7 (-0.61%)

ABBV AbbVie
$113.99 /

-0.7 (-0.61%)

ABBV AbbVie
$113.99 /

-0.7 (-0.61%)

Downgrade
FMC Corporation downgraded to Hold from Buy at Vertical Research » 08:01
06/24/21
06/24
08:01
06/24/21
08:01
FMC

FMC Corporation

/

+

Vertical Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FMC FMC Corporation
/

+

FMC FMC Corporation
/

+

05/06/21
Fly Intel: Top five analyst downgrades
05/06/21 Citi
FMC Corporation downgraded to Neutral from Buy at Citi
02/11/21 Monness Crespi
FMC Corporation upgraded to Buy from Neutral at Monness Crespi
01/20/21 RBC Capital
FMC Corporation price target lowered to $136 from $145 at RBC Capital
FMC FMC Corporation
/

+

FMC FMC Corporation
/

+

FMC FMC Corporation
/

+

Initiation
OppFi initiated with a Buy at DA Davidson » 08:01
06/24/21
06/24
08:01
06/24/21
08:01
FGNA

FG New America Acquisition

$10.23 /

+0.035 (+0.34%)

, OPFI

OppFi

/

+

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Corbus Pharmaceuticals trading halted, news pending  08:00
06/24/21
06/24
08:00
06/24/21
08:00
CRBP

Corbus Pharmaceuticals

$1.98 /

+0.055 (+2.86%)

 
ShowHide Related Items >><<
CRBP Corbus Pharmaceuticals
$1.98 /

+0.055 (+2.86%)

CRBP Corbus Pharmaceuticals
$1.98 /

+0.055 (+2.86%)

10/08/20 H.C. Wainwright
Corbus Pharmaceuticals price target lowered to $3 from $6 at H.C. Wainwright
10/06/20 Roth Capital
Corbus Pharmaceuticals price target lowered to $1.22 from $3 at Roth Capital
09/08/20 Jefferies
Corbus Pharmaceuticals downgraded to Hold from Buy at Jefferies
09/08/20 Oppenheimer
Corbus Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
CRBP Corbus Pharmaceuticals
$1.98 /

+0.055 (+2.86%)

Options
Uniti Group put buyer realizes 38% same-day gains » 08:00
06/24/21
06/24
08:00
06/24/21
08:00
UNIT

Uniti Group

$10.45 /

-0.13 (-1.23%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UNIT Uniti Group
$10.45 /

-0.13 (-1.23%)

UNIT Uniti Group
$10.45 /

-0.13 (-1.23%)

11/16/20 Citi
Uniti Group resumed with a Neutral from Sell at Citi
09/11/20 Raymond James
Raymond James backs Strong Buy for Uniti ahead of Windstream reorganization
08/12/20 Wells Fargo
Uniti Group upgraded to Equal Weight at Wells Fargo
08/12/20 Wells Fargo
Uniti Group upgraded to Equal Weight from Underweight at Wells Fargo
UNIT Uniti Group
$10.45 /

-0.13 (-1.23%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.